ATAD2 is overexpressed in various human malignancies, including HCC; it is a potential proliferation marker for liver regeneration and is a poor prognostic marker for hepatocellular carcinoma after curative resection [61,62]. The gene discussed is ATAD2; the disease is hepatocellular carcinoma.